American College of Cardiology releases new guide for treating atherosclerotic cardiovascular disease

The American College of Cardiology recently made new recommendations for the treatment of high-risk atherosclerotic cardiovascular disease in patients with continuous hypertriglyceridemia.

Advertisement

The college stated that triglyceride-lowering therapies could be considered to lower ASCVD risk in patients following the use of LDL-C lowering therapy. The organization also noted additional stresses and lifestyle choices that could reduce the risk of ASCVD, including heart-healthy diets, regular physical activity, not using tobacco, minimal alcohol consumption and maintaining a healthy weight.

The recommendations were published July 28 in the Journal of the American College of Cardiology.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement

Comments are closed.